[Retracted] Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma

<div>Comparison of the OS and PFS in two years. (a) The OS of the research group was higher than that of the control group in 2 years. (b) The PFS of the research group was higher than that of the control group in 2 years.</div>

Emergency Medicine International

fig1

Figure 1

Figure 1: [Retracted] Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma 

Figure 1 | [Retracted] Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma 